Literature DB >> 18337179

Effective treatments of prolonged status epilepticus in developing rats.

Henry Hasson1, Mimi Kim, Solomon L Moshé.   

Abstract

We determined the efficacy of diazepam (DZP) and pentobarbital (PTB) in controlling prolonged status epilepticus (SE) in developing rats. One-hour-long SE was induced with kainic acid (KA) or lithium pilocarpine (Li-Pilo) in Postnatal Day 9 (P9), 15 (P15) and 21 (P21) rats, which were then treated with varying doses of DZP (20-60 mg/kg) or PTB (20-60 mg/kg). At P9, neither drug stopped SE, and higher doses could not be used because of high mortality. At P15 and P21, DZP and PTB stopped both behavioral and electrographic SE in a dose-dependent fashion, with similar efficacy in the two seizure models. DZP stopped SE significantly faster than PTB. Administration of a low dose of PTB (20mg/kg) following an initially ineffective treatment with DZP 20mg/kg stopped SE in all rats. The data suggest that high doses of DZP and PTB are needed to stop prolonged SE in developing rats, but their effectiveness is age dependent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337179      PMCID: PMC2517630          DOI: 10.1016/j.yebeh.2008.02.008

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  38 in total

1.  Antiepileptic drugs and apoptotic neurodegeneration in the developing brain.

Authors:  Petra Bittigau; Marco Sifringer; Kerstin Genz; Ellen Reith; Dana Pospischil; Suresh Govindarajalu; Mark Dzietko; Stefanie Pesditschek; Ingrid Mai; Krikor Dikranian; John W Olney; Chrysanthy Ikonomidou
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

2.  Rodent brain growth stages: an analytical review.

Authors:  A Gottlieb; I Keydar; H T Epstein
Journal:  Biol Neonate       Date:  1977

3.  A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus.

Authors:  B K Alldredge; A M Gelb; S M Isaacs; M D Corry; F Allen; S Ulrich; M D Gottwald; N O'Neil; J M Neuhaus; M R Segal; D H Lowenstein
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

4.  Sexual dimorphism and developmental regulation of substantia nigra function.

Authors:  J Velísková; S L Moshé
Journal:  Ann Neurol       Date:  2001-11       Impact factor: 10.422

5.  Sex-specific KCC2 expression and GABA(A) receptor function in rat substantia nigra.

Authors:  Aristea S Galanopoulou; Andreas Kyrozis; Olga I Claudio; Patric K Stanton; Solomon L Moshé
Journal:  Exp Neurol       Date:  2003-10       Impact factor: 5.330

6.  Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus.

Authors:  Dorothy M Jones; Nadia Esmaeil; Stephen Maren; Robert L Macdonald
Journal:  Epilepsy Res       Date:  2002-08       Impact factor: 3.045

Review 7.  Effects of brief seizures during development.

Authors:  Libor Velísek; Solomon L Moshé
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

8.  Diazepam terminates brief but not prolonged seizures in young, naïve rats.

Authors:  Howard P Goodkin; Xianzeng Liu; Gregory L Holmes
Journal:  Epilepsia       Date:  2003-08       Impact factor: 5.864

9.  Artificial rearing of mouse pups: development of a mouse pup in a cup model.

Authors:  Elizabeth A Beierle; Mike K Chen; Joseph E Hartwich; Meera Iyengar; Wei Dai; Nan Li; Vince Demarco; Josef Neu
Journal:  Pediatr Res       Date:  2004-06-04       Impact factor: 3.756

Review 10.  Stressed-out, or in (utero)?

Authors:  Sarit Avishai-Eliner; Kristen L Brunson; Curt A Sandman; Tallie Z Baram
Journal:  Trends Neurosci       Date:  2002-10       Impact factor: 13.837

View more
  8 in total

1.  Status epilepticus: Role for etiology in determining response to benzodiazepines.

Authors:  Suchitra Joshi; Karthik Rajasekaran; Kyle M Hawk; Stephen J Chester; Howard P Goodkin
Journal:  Ann Neurol       Date:  2018-04-10       Impact factor: 10.422

Review 2.  Epileptogenesis in neonatal brain.

Authors:  Anna-Maria Katsarou; Aristea S Galanopoulou; Solomon L Moshé
Journal:  Semin Fetal Neonatal Med       Date:  2017-12-23       Impact factor: 3.926

Review 3.  Issues related to development of new antiseizure treatments.

Authors:  Karen S Wilcox; Tracy Dixon-Salazar; Graeme J Sills; Elinor Ben-Menachem; H Steve White; Roger J Porter; Marc A Dichter; Solomon L Moshé; Jeffrey L Noebels; Michael D Privitera; Michael A Rogawski
Journal:  Epilepsia       Date:  2013-08       Impact factor: 5.864

4.  Harmful effect of kainic acid on brain ischemic damage is not related to duration of status epilepticus.

Authors:  Henry Hasson; Samit Malhotra; Filippo S Giorgi; Daniel M Rosenbaum; Solomon L Moshé
Journal:  Neurol Sci       Date:  2009-09-25       Impact factor: 3.307

Review 5.  Why is the developing brain more susceptible to status epilepticus?

Authors:  Antonietta Coppola; Solomon L Moshé
Journal:  Epilepsia       Date:  2009-12       Impact factor: 5.864

6.  Serotonin 1A receptor inhibits the status epilepticus induced by lithium-pilocarpine in rats.

Authors:  Yi Yang; Yi Guo; Yifang Kuang; Shan Wang; Yan Jiang; Yao Ding; Shuang Wang; Meiping Ding
Journal:  Neurosci Bull       Date:  2014-01-15       Impact factor: 5.203

7.  Neuronal degeneration is observed in multiple regions outside the hippocampus after lithium pilocarpine-induced status epilepticus in the immature rat.

Authors:  E A Scholl; F E Dudek; J J Ekstrand
Journal:  Neuroscience       Date:  2013-07-27       Impact factor: 3.590

8.  Not all that glitters is gold: A guide to critical appraisal of animal drug trials in epilepsy.

Authors:  Aristea S Galanopoulou; Wenzhu B Mowrey
Journal:  Epilepsia Open       Date:  2016-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.